ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,442,827, issued on Oct. 14, was assigned to UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH (Fort Worth, Texas) and THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (Norman, Okla.).

"Detection and treatment of conditions related to luteinizing hormone/follicle-stimulating hormone (LH/FSH) levels" was invented by Dimitrios Karamichos (Carrollton, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for detecting or predicting a disease or condition related to a ratio of luteinizing hormone to follicle-stimulating hormone (LH/FSH ratio) by obtaining or having obtained a biological sample from a subject; and dete...